Quirk RA - Search Results

1

The Intercostal NMJ Assay: a new alternative to the conventional LD50 assay for the determination of the therapeutic potency of botulinum toxin preparations.

Huber A, France RM, Riccalton-Banks L, McLaren J, Cox H, Quirk RA, Shakesheff KM, Thompson D, Panjwani N, Shipley S, Pickett A. Huber A, et al. Among authors: quirk ra. Altern Lab Anim. 2008 May;36(2):141-52. doi: 10.1177/026119290803600205. Altern Lab Anim. 2008. PMID: 18522482

2

Growth factor release from tissue engineering scaffolds.

Whitaker MJ, Quirk RA, Howdle SM, Shakesheff KM. Whitaker MJ, et al. Among authors: quirk ra. J Pharm Pharmacol. 2001 Nov;53(11):1427-37. doi: 10.1211/0022357011777963. J Pharm Pharmacol. 2001. PMID: 11732745 Review.

3

Recent advances in tissue engineering: an invited review.

Pearson RG, Bhandari R, Quirk RA, Shakesheff KM. Pearson RG, et al. Among authors: quirk ra. J Long Term Eff Med Implants. 2002;12(1):1-33. J Long Term Eff Med Implants. 2002. PMID: 12096640 Review.

4

Recent Advances in Tissue Engineering.

Pearson RG, Bhandari R, Quirk RA, Shakesheff KM. Pearson RG, et al. Among authors: quirk ra. J Long Term Eff Med Implants. 2017;27(2-4):199-231. doi: 10.1615/JLongTermEffMedImplants.v27.i2-4.70. J Long Term Eff Med Implants. 2017. PMID: 29773040 Review.

5

Poly(L-lysine)-GRGDS as a biomimetic surface modifier for poly(lactic acid).

Quirk RA, Chan WC, Davies MC, Tendler SJ, Shakesheff KM. Quirk RA, et al. Biomaterials. 2001 Apr;22(8):865-72. doi: 10.1016/s0142-9612(00)00250-7. Biomaterials. 2001. PMID: 11246955

6

Injectable and porous PLGA microspheres that form highly porous scaffolds at body temperature.

Qutachi O, Vetsch JR, Gill D, Cox H, Scurr DJ, Hofmann S, Müller R, Quirk RA, Shakesheff KM, Rahman CV. Qutachi O, et al. Among authors: quirk ra. Acta Biomater. 2014 Dec;10(12):5090-5098. doi: 10.1016/j.actbio.2014.08.015. Epub 2014 Aug 23. Acta Biomater. 2014. PMID: 25152354 Free PMC article.

7

A biodegradable antibiotic-impregnated scaffold to prevent osteomyelitis in a contaminated in vivo bone defect model.

McLaren JS, White LJ, Cox HC, Ashraf W, Rahman CV, Blunn GW, Goodship AE, Quirk RA, Shakesheff KM, Bayston R, Scammell BE. McLaren JS, et al. Among authors: quirk ra. Eur Cell Mater. 2014 Jun 8;27:332-49. doi: 10.22203/ecm.v027a24. Eur Cell Mater. 2014. PMID: 24908426 Free article.

8

Cell-type-specific adhesion onto polymer surfaces from mixed cell populations.

Quirk RA, Kellam B, Bhandari RN, Davies MC, Tendler SJ, Shakesheff KM. Quirk RA, et al. Biotechnol Bioeng. 2003 Mar 5;81(5):625-8. doi: 10.1002/bit.10502. Biotechnol Bioeng. 2003. PMID: 12514812

9

Human osteoprogenitor growth and differentiation on synthetic biodegradable structures after surface modification.

Yang XB, Roach HI, Clarke NM, Howdle SM, Quirk R, Shakesheff KM, Oreffo RO. Yang XB, et al. Bone. 2001 Dec;29(6):523-31. doi: 10.1016/s8756-3282(01)00617-2. Bone. 2001. PMID: 11728922

10

Cell function and viability in glucose polymer peritoneal dialysis fluids.

Liberek T, Topley N, Mistry CD, Coles GA, Morgan T, Quirk RA, Williams JD. Liberek T, et al. Among authors: quirk ra. Perit Dial Int. 1993;13(2):104-11. Perit Dial Int. 1993. PMID: 8388260

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters